CSIMarket
 

Purple Biotech Ltd   (PPBT)
Other Ticker:  
 

Purple Biotech Ltd 's Working Capital Per Sales

PPBT's Working Capital and Revenue growth



PPBT Working Capital Per Revenue (Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Working Capital Change -59.51 % -59.51 % -59.51 % -59.51 % 15.17 %
Y / Y Revenue Change - - - - -
Working Capital Per Revenue - - - - -
Total Ranking # # # # #
Seq. Working Capital Change 0 % 0 % 0 % -59.51 % 0 %
Seq. Revenue Change - - - - -





Comment on PPBT's Working Capital Per Revenue in the fourth quarter 2022


Within Healthcare sector Purple Biotech Ltd has achieved the lowest Working Capital Per Revenue. While Working Capital Per Revenue remained unchanged in the Q4 2022 relative to the prior quarter at no. .
Working Capital Per Revenue Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Working Capital Per Revenue Statistics
High Average Low
0
0
0
 



Financial Statements
Purple Biotech Ltd 's Working Capital $ 26 Millions Visit PPBT's Balance sheet
Purple Biotech Ltd 's Revenues $ 0 Millions Visit PPBT's Income Statement
Where are PPBT's Sales coming from? Visit PPBT's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2022, within Healthcare Sector Working Capital Per Revenue
Date modified: 2023-03-23T13:12:32+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com